Biostem Blog
The Future of Chronic Wound Care: What to Expect in 2025
As we look ahead to 2025, the landscape of chronic wound care is poised for remarkable advancements. Emerging technologies and innovative approaches promise to reshape how wounds are managed, with…
Understanding Hypergranulation: Causes, Effects, and Treatment
Hypergranulation is a term used to describe excessive granulation tissue formation at the site of a wound. While some granulation tissue is essential for wound healing, an overabundance can lead…
Multidisciplinary Care for Chronic Wounds
Chronic wounds, which are wounds that do not heal in the expected time frame (usually about three months), require specialized treatment strategies. Here are some of the most common treatment…
The Transformative Impact of Effective Wound Care on the Lives of Patients
Wounds, whether acute or chronic, significantly impact a patient’s quality of life. They can affect physical, emotional, and social well-being, leading to prolonged suffering and diminished life satisfaction. However, advancements…
Biologics in Wound Care
Biologics are products derived from living cells or organisms that mimic natural substances in the body to promote healing. They address various aspects of wound healing, including cellular growth, extracellular…
Transforming Wound Management: The Impact of VENDAJE on Chronic Wounds
In the ever-evolving field of wound care, chronic wounds present some of the most persistent and challenging cases for healthcare providers. These wounds, which include diabetic foot ulcers, venous leg…
Transforming Diabetic Foot Ulcer Treatment with VENDAJE®
Better Processing leads to Better Results Diabetic foot ulcers (DFUs) pose a daunting challenge for both patients and healthcareproviders, significantly impacting quality of life and increasing the risk of complications….
Guidance for Current Good Tissue Practice
Current Good Tissue Practices Current Good Tissue Practices (CGTP) are governing methods and practices outlined by the US Food and Drug Administration (FDA). US-based tissue manufacturers are required to follow…